FDA
-
-
-
-
-
-
-
Telix doses first patient in Phase 3 kidney cancer drug trial
-
-
-
-
-
-
-
Telix and United Imaging Announce Strategic Theranostics Collaboration
-
-
-
-
-
-
-
Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
-
-
-
-
-
-
-
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
-
-
-
-
-
-
-
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study
-
-
-
-
-
-
-
TLX250-CDx (Zircaix) Included in Leading International Guidelines for Renal Imaging
-
-
-
-
-
-
-
Gozellix Receives Permanent HCPCS Code
-
328,337 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

